© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Esperion Therapeutics, Inc. (ESPR) shows an Average True Range (ATR) of 0.22 and an Enterprise Value of 821.69M. Its average trading volume over the past 3 months is 6.89M, indicating liquidity. These fundamental metrics provide insight into ESPR's underlying financial health and market activity.
Esperion Therapeutics, Inc. (ESPR) technical indicators as of December 22, 2025: the SMA 20 is 4.93%, SMA 50 at 23.37%, and SMA 200 at 100.25%. The RSI 14 value is 60.89, suggesting its current momentum. These technical analysis signals help assess ESPR's price trends and potential future movements.
Esperion Therapeutics, Inc. (ESPR) stock performance overview as of December 22, 2025: The 52-week high is $4.13 (currently -4.84% below), and the 52-week low is $0.693 (currently 467.51% above). Over the past year, ESPR's performance is 74.67%, compared to the S&P 500's 12.87% change.
According to market data, Esperion Therapeutics, Inc. (ESPR) stock's recent performance metrics show that over the last month, ESPR is 38.87%, with a Year-to-Date (YTD) performance of 78.64%. Over the past year, the stock has seen a 74.67% change. These figures summarize ESPR's price movements across various periods, reflecting its historical returns.
According to current financial data, ESPR stock's P/E (TTM) ratio is -7.95, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ESPR, including P/S (2.56), P/B (-1.73), and P/FCF (-8.32), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.